During the past decade, SAL Hospital And Medical Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SAL Hospital And Medical Institute" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Population Health Research Institute" with 1 trials sponsored and "Stempeutics Research Pvt Ltd" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SAL Hospital And Medical Institute" #1 collaborator was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator, "Centre for Chronic Disease Control, India" with 1 trials as a collaborator, "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials as a collaborator and "Charles University, Czech Republic" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "SAL Hospital And Medical Institute" are "Cardiovascular Disease" (3 trials), "Coronary Artery Disease" (2 trials), "Coronary Disease" (2 trials), "Coronary Restenosis" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "SAL Hospital And Medical Institute" in a lesser frequency.

Most popular intervention types in "SAL Hospital And Medical Institute" are "Drug" (5 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "ABSORB BVS" (1 trials), "Coronary Artery Bypass Graft with the use of CPB" (1 trials) and "Coronary Artery Bypass Graft without the use of CPB" (1 trials). Other intervention names were less common.

The vast majority of trials in "SAL Hospital And Medical Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "SAL Hospital And Medical Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in SAL Hospital And Medical Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in SAL Hospital And Medical Institute, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".